Is Chinese products Rapid Testing Kits are faulty
According to sources china on tuesday said it was "deeply concerned" over the evaluation result of the COVID-19 rapid testing kits supplied to india by two Chinese companies and subsequent decision by the indian Council of Medical Research (ICMR) to not use the equipment, and hoped that New delhi will resolve the issue "reasonably and properly". The ICMR on monday asked states and union territories to stop using the test kits procured from the Chinese companies Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics due to "wide variations" in their performance.
"We are deeply concerned with the evaluation results and the decision made by the indian Council of Medical Research. china attaches great importance to the quality of exported medical products," Chinese embassy Spokeperson Ji Rong said. In a statement, she also said it is "unfair and irresponsible for certain individuals to label Chinese products as ''faulty'' and look at the issues with preemptive prejudice." Ji, however, did not clarify who are the individuals she was referring to. At the same time, the spokesperson said china will continue to support India''s fight against the pandemic and will jointly work with New delhi to overcome the challenge "at an early date" to protect people of the two countries from the infection.
india procured around 5,00,000 rapid antibody test kits from the two Chinese firms nearly two weeks back and they were distributed to several states reporting rising cases of the coronavirus infection. In a communication on monday, the ICMR asked states and union territories to return the kits to the central government so that they can be sent back to the suppliers. The government said not a single rupee will be lost as payments were not made to the Chinese suppliers of the kits.